ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 216 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q3 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,657,204 | -1.9% | 278,326 | -6.0% | 0.01% | 0.0% |
| Q2 2023 | $3,729,739 | -5.9% | 296,011 | -2.6% | 0.01% | -11.1% |
| Q1 2023 | $3,964,238 | -26.9% | 303,773 | -1.2% | 0.01% | -35.7% |
| Q4 2022 | $5,425,782 | -11.5% | 307,584 | -23.6% | 0.01% | -17.6% |
| Q3 2022 | $6,134,000 | +1.7% | 402,753 | -1.0% | 0.02% | +13.3% |
| Q2 2022 | $6,033,000 | -66.4% | 406,812 | -49.0% | 0.02% | -21.1% |
| Q1 2022 | $17,966,000 | +112.0% | 797,762 | +73.7% | 0.02% | +5.6% |
| Q4 2021 | $8,474,000 | -15.3% | 459,278 | -38.6% | 0.02% | -28.0% |
| Q3 2021 | $10,003,000 | -39.5% | 748,191 | -16.2% | 0.02% | -45.7% |
| Q2 2021 | $16,525,000 | +2.4% | 892,746 | -16.9% | 0.05% | -17.9% |
| Q1 2021 | $16,133,000 | +46.6% | 1,074,481 | +41.0% | 0.06% | +36.6% |
| Q4 2020 | $11,008,000 | +188.2% | 762,298 | +62.5% | 0.04% | +115.8% |
| Q3 2020 | $3,819,000 | – | 469,140 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 1,500,000 | $21,593,000 | 4.50% |
| KESTREL INVESTMENT MANAGEMENT CORP | 445,500 | $6,433,000 | 3.14% |
| Adirondack Research & Management Inc. | 155,088 | $2,239,000 | 3.06% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 9,398,617 | $135,716,029,000 | 2.92% |
| Waterfront Wealth Inc. | 136,976 | $1,978,000 | 1.40% |
| Smith, Graham & Co., Investment Advisors, LP | 1,008,283 | $14,560,000 | 1.34% |
| S&T BANK/PA | 475,184 | $6,862,000 | 1.23% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,132,500 | $16,354,000 | 0.98% |
| HENNESSY ADVISORS INC | 1,024,100 | $14,788,000 | 0.95% |
| BEACONLIGHT CAPITAL, LLC | 208,546 | $3,011,000 | 0.91% |